Project Grant K23AG093166

Award Date 8/1/25
Completion Date 4/30/30
Dollars Obligated $164K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award of $2,557,260.00 from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) will support a longitudinal study to investigate the transition from midlife to early late-life and the development of early clinical Alzheimer's disease and related dementias (AD/ADRD) among diverse populations. The study, led by the University of California, San Francisco, will conduct cognitive assessments and AD/ADRD adjudication on participants in the...
This Project Grant award for $191,196.00 from the National Institute on Aging (CFDA 93.866 Aging Research) supports the mentoring activities of Dr. Winston Chiong, a behavioral neurologist and bioethicist at the University of California, San Francisco (UCSF). The primary goal is to expand Dr. Chiong's mentorship of junior scholars in an interdisciplinary research program focused on decision-making challenges associated with Alzheimer's disease and other dementias. The research specifically...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $162,000.00 to the University of South Carolina to develop and implement an equity-driven research training program. The program aims to build capacity and expertise in integrating community engagement, health communication, and implementation science research to advance the science on Alzheimer's disease and related dementias (ADRD) disparities and outcomes, particularly among...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will investigate the impact of Historically Black Colleges and Universities (HBCUs) on late-life cognition and Alzheimer's disease and related dementias (ADRD) outcomes among Black adults. The $520,040.19 award, effective September 1, 2024 through May 31, 2027, will leverage three large national panel datasets to evaluate the causal effects of HBCU attendance and proximity, as well as state/federal...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by Dr. Jinshil Hyun at the Albert Einstein College of Medicine to investigate the influence of neighborhood characteristics, including both objective and subjective measures as well as GPS-based activity space, on cognitive decline, Alzheimer's disease and related dementias (ADRD), and cognitive health disparities. The $448,992 award covers the period from February 1, 2025 to...
This National Institute on Aging (NIA) Project Grant award (CFDA 93.866 - Aging Research) for $124,786 provides funding to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at determining the genetic drivers of ancestry-specific differential penetrance of the APOE4 isoform in sporadic Alzheimer's disease. The key objectives of this 2.5-year project are to: 1) Functionally prioritize a comprehensive set of 10,661 analytically-nominated variants in the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Trustees of Columbia University provides $251,071 to identify genes that interact with cardio-cerebrovascular risk factors (CVRFs) to influence Alzheimer's disease (AD) risk, and investigate epigenomic and transcriptomic signatures that interact with vascular pathologies to confer AD risk. The award aims to elucidate the genetic architecture between AD and CVRFs, with a focus on diverse...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a $770,558 research study at Wake Forest University Health Sciences (WFUHS) from July 1, 2025 to March 31, 2030. The study aims to establish connections between Alzheimer's disease-related genomic markers and neuroimaging phenotypes, in order to determine the heterogeneity of Alzheimer's disease subtypes and their association with the clinical onset of dementia. The research team will...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) will provide $395,494 to The Regents of the University of California, San Francisco (UCSF) to conduct a mixed-methods investigation on the impact of structural gendered racism on cognitive aging and Alzheimer's disease risk among Black women. The key objectives are to: (1) develop and validate a multidimensional index of structural gendered racism using qualitative interviews, (2)...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $3,845,311 to the University of California, San Diego (UCSD) to investigate the early determinants of Alzheimer's disease (AD) using age-equivalent neurons derived from mild cognitive impairment (MCI) patients. The project aims to better understand the convergence of risk factors, including polygenic variants and biological aging, on molecular pathways that initiate and...

This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 - Aging Research will support Charles Windon, MD, a behavioral neurologist and assistant professor at the University of California, San Francisco (UCSF) Memory and Aging Center, in becoming an independent clinical researcher focused on biomarker-informed inequities in Alzheimer's disease and related dementias (AD/ADRD).

The $164,117 award, effective August 1, 2025 through April 30, 2030, will allow Dr. Windon to pursue training goals in PET imaging analysis, plasma biomarker analysis, advanced statistical methodology, and analytic approaches to individual- and neighborhood-level social determinants of health (SDOH). The research aims to investigate how global B-amyloid burden, phosphorylated tau (p-tau) 217, and neurofilament light (NFL) biomarkers are associated with AD/ADRD among diverse populations with varying SDOH profiles. The findings will inform future R01 research to develop and explore models validated in larger cohorts to identify key pathological contributions to cognitive impairment for ethnoculturally diverse individuals.

Generated 8/5/25, 5:39 AM